Skip to main content
Clinical Trials/CTRI/2020/09/028027
CTRI/2020/09/028027RecruitingPhase 2/3

Efficacy of Rectal Indomethacin in prevention of post-operative pancreatitis after pancreaticoduodenectomy – a randomized controlled trial

Institute of Liver and Biliary Sciences1 site in 1 country80 target enrollmentStarted: September 30, 2020Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Recruiting
Enrollment
80
Locations
1
Primary Endpoint
Incidence of Post-operative Pancreatitis

Study Overview

Brief Summary

Pancreatico-duodenectomy is one of the commonly performed procedure for

periampullary/distal cholangio/head of pancreas carcinoma. Post operative pancreatitis is an

emerging concept, recently being studied as one of the most important contributing factor of

Post-operative pancreatic fistula, which is one of the major complication of

pancreatoduodenectomy. Rectal indomethacin, a type of non-steroidal anti-inflammatory drug,

when given in a single dose has been shown to prevent pancreatitis in patients undergoing

ERCP. In this study, we will be administering rectal indomethacin at the time of induction of

anesthesia to the experimental arm of the study and compare the results in terms of incidence of

post-operative pancreatitis in the two groups.

Study Design

Study Type
Interventional
Allocation
Permuted block randomization, fixed
Masking
Participant and Investigator Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 80.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • All consenting adults planned to undergo pancreatoduodenectomy.

Exclusion Criteria

  • Patients refusing to consent
  • History of asthma
  • History of allergic reactions to NSAIDs
  • History of renal dysfunction or CKD
  • E/o Internal hemorrhoids on examination
  • Patients on Anti-platelet drugs.

Outcomes

Primary Outcomes

Incidence of Post-operative Pancreatitis

Time Frame: Within 30 days of surgery

Secondary Outcomes

  • Post-operative pancreatic fistula rate(within 30 days of surgery)
  • Post-pancreaticoduodenectomy hemorrhage rate(within 30 days of surgery)
  • Delayed Gastric emptying rate(within 30 days of surgery)
  • Intra-abdominal collections/abscess rates(within 30 days of surgery)
  • Duration of ICU stay(within 30 days of surgery)
  • Length of Hospital Stay(within 30 days of surgery)
  • Risk factors for post-operative pancreatitis(within 30 days of surgery)

Investigators

Sponsor Class
Research institution and hospital

Study Sites (1)

Loading locations...

Similar Trials